← Back to Search

SHE-WOMEN Program for Cervical Cancer Prevention (SHE-WOMEN Trial)

N/A
Waitlist Available
Led By Megha Ramaswamy, PhD, MPH
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post behavioral intervention, 24 months post behavioral intervention, 36 months post behavioral intervention
Awards & highlights

SHE-WOMEN Trial Summary

This trial will test an expansion of an existing cervical cancer prevention intervention to a broader population to see if it is effective and sustainable.

Who is the study for?
This trial is for women who are scheduled to leave jail within the next three days and are interested in improving their knowledge about sexual health, including cervical and breast cancer prevention, birth control, and preventing sexually transmitted infections. Women showing severe psychological distress or those actively intoxicated cannot participate.Check my eligibility
What is being tested?
The SHE-WOMEN intervention is being tested to see if it can help reduce health disparities by educating vulnerable populations of women on various aspects of sexual health. The study aims to create a sustainable model for disseminating this information effectively.See study design
What are the potential side effects?
Since the intervention involves education and empowerment rather than medical treatment, there are no direct side effects associated with medications or procedures. However, participants may experience emotional responses to the material.

SHE-WOMEN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post behavioral intervention, 24 months post behavioral intervention, 36 months post behavioral intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post behavioral intervention, 24 months post behavioral intervention, 36 months post behavioral intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Beliefs related to Breast Cancer
Body Weight Changes
Change in HPV Vaccination receipt
+16 more

SHE-WOMEN Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Deliver text-Web intervention to (N ~100) women Researchers will deliver the integrated, multimedia electronic women's health literacy intervention arm of SHEWomen in text-Web format for individuals recently released from jail. Two health educators will be responsible for delivering content to participants, with an estimated contact time of ~10 hours pushed to participants over approximately a 5-day period.
Group II: ControlActive Control1 Intervention
15 minute discharge planning session with health educator Health education booklet containing SHE-Women intervention content in print form(N~100) access to health educator via text message

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
458 Previous Clinical Trials
168,809 Total Patients Enrolled
Megha Ramaswamy, PhD, MPHPrincipal Investigator - University of Kansas School of Medicine
University of Kansas Medical Center
1 Previous Clinical Trials
261 Total Patients Enrolled

Media Library

SHE-WOMEN Clinical Trial Eligibility Overview. Trial Name: NCT03984695 — N/A
Sexually Transmitted Infections Research Study Groups: Control, Intervention
Sexually Transmitted Infections Clinical Trial 2023: SHE-WOMEN Highlights & Side Effects. Trial Name: NCT03984695 — N/A
SHE-WOMEN 2023 Treatment Timeline for Medical Study. Trial Name: NCT03984695 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently eligible for this research trial?

"Affirmative, clinicaltrials.gov reveals that recruitment has opened for this research project which was initially posted on the 11th of November 2019 and recently modified on the 2nd of February 2021. 200 applicants are sought from a single site."

Answered by AI

Are there still opportunities to join this medical experiment?

"Affirmative. Data hosted on clinicaltrials.gov shows that this research is actively enrolling participants, with the study first advertised on November 11th 2019 and last edited today February 11th 2021. The trial seeks 200 patients from a single medical centre."

Answered by AI
Recent research and studies
~52 spots leftby Mar 2025